// App-Quantinova.ai

B22 : RAS Inhibition Attenuates Urine Angiotensin II-Regulated Proteins Associated with Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.

Researchers

Presenter

  • Z. Mohammed-Ali

Principal Investigators

  • S. Reid

  • P. Yip

  • H. Cardinal

  • M.-J. Hbert

  • Y. Li

  • S. Kim

  • A. Konvalinka

Medical Centers

  • Universtiy Health Network, Toronto, ON, Canada

  • Centre de Recherche du Centre Hospitalier de l'Universit&eacute

  • de Montréal, Montreal, QC, Canada

  • Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada

  • Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Laminin Subunit Beta 2

  • Lysophospholipase 1

  • Thrombospondin-1

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved